Inhibition of lymphocyte proliferative responses by anti-HL-A alloantisera.
D000042:Absorption; D000918:Antibody Specificity; D002478:Cells, Cultured; D003037:Cobalt Radioisotopes; D003601:Cytotoxicity Tests, Immunologic; D005260:Female; D006649:Histocompatibility Antigens; D006650:Histocompatibility Testing; D006801:Humans; D007106:Immune Sera / Q000494:pharmacology*; D007140:Immunoglobulin Fab Fragments / Q000302:isolation & purification; D007074:Immunoglobulin G / Q000302:isolation & purification; D007165:Immunosuppression Therapy; D007518:Isoantibodies / Q000032:analysis; D037102:Lectins; D008213:Lymphocyte Activation / Q000187:drug effects* / Q000528:radiation effects; D007959:Lymphocyte Culture Test, Mixed; D008214:Lymphocytes / Q000276:immunology; D008297:Male; D014066:Palatine Tonsil / Q000166:cytology; D011247:Pregnancy; D011830:Radiation Effects; D013936:Thymidine / Q000378:metabolism; D014316:Tritium
D003037:Cobalt Radioisotopes; D006649:Histocompatibility Antigens; D007106:Immune Sera; D007140:Immunoglobulin Fab Fragments; D007074:Immunoglobulin G; D007518:Isoantibodies; D037102:Lectins; D014316:Tritium; D013936:Thymidine